HA Fillers Report Highlights Gap Between Perception and Outcomes
Emily Hu, MD, shares insights from a recent report on HA injectables, examining patient perceptions, persistent myths, and clinical realities.
Emily Hu, MD, shares insights from a recent report on HA injectables, examining patient perceptions, persistent myths, and clinical realities.
The botulinum neurotoxin type E candidate is designed for a faster onset and shorter duration of effect than currently available neurotoxin treatments.